School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The relevance of the study is determined by the low efficiency of treatment of type 1 diabetes mellitus (T1DM) despite the use of various modern expensive technologies. Objective. Evaluation of the glycemic variability (GV) in T1DM patients on insulin pump therapy before and 12 months after training with the use of a new education module to increase the effectiveness of insulin pump therapy. Methods. Patients before training (group 1, n=18) and 12 months after (group 2, n=18) underwent determination of the glycated hemoglobin (HbA1c) level, GV parameters, and questionnaire survey. Results. Patients in group 1 used the capabilities of the insulin pump worse than in group 2 - 19.8±2.6 and 27.2±2.43 points, respectively (p<0.001). Before training, patients experienced a significantly greater fear of hypoglycemia than after completion of training (71.9±10.5 and 62.4±7.75 points, respectively, p=0.004). The HbAu level in group 1 was significantly higher than in group 2 and amounted to 7.38±1.12% and 6.71±0.54%, respectively, p=0.028. The postprandial glycemic index (MAGE) was significantly lower after training - in group 1 it was 3.62 [2.65; 4.77] mmol/L, in group 2 - 2.44 [2.2; 2.86] mmol/L (p=0.006). The glycemic lability index (LI) was also significantly higher in group 1 than in group 2 - 12.0 [8.35; 27.3] and 12.0[8.35; 27.3] mmol/L2/h, respectively, p=0.041. Conclusion. The HbAu level, the postprandial glycemic index (MAGE) and the glycemic lability index (LI) in T1DM patients on insulin pump therapy after enrolling in school of diabetes using education module on insulin pump therapy were significantly lower (p=0.028, p=0.006, p=0.041, respectively). After completing the training, patients used the capabilities of the insulin pump significantly better (p<0,001) and experienced significantly less fear of hypoglycemia according to the HFS-II scale (p=0,004).

Full Text

Restricted Access

About the authors

A. V Lisker

Saint Petersburg State Pavlov Medical University; Research Institute of Cardiovascular Diseases, Scientific and Clinical Research Center

A. R Volkova

Saint Petersburg State Pavlov Medical University; Research Institute of Cardiovascular Diseases, Scientific and Clinical Research Center

Email: volkovaa@mail.ru

M. E Chernaya

Saint Petersburg State Pavlov Medical University; Research Institute of Cardiovascular Diseases, Scientific and Clinical Research Center

V. S Mozgunova

Saint Petersburg State Pavlov Medical University; Research Institute of Cardiovascular Diseases, Scientific and Clinical Research Center

M. B Durdyeva

Saint Petersburg State Pavlov Medical University; Research Institute of Cardiovascular Diseases, Scientific and Clinical Research Center

References

  1. Стотикова О.В., Малкоч А.В., Логачев М.Ф. Клиническая и экономическая эффективность использования современных алгоритмов помповой инсулинотерапии в педиатрической практике. Лечащий врач. 2019;12:26-30
  2. Аметов А.С., Валитов Б.И., Черникова Н.А. Терапевтическое обучение больных: прошлое, настоящее, будущее. Сахарный диабет. 2012;1(15):71-77
  3. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: распространенность, заболеваемость, смертность, параметры углеводного обмена и структура сахароснижающей терапии по данным Федерального регистра сахарного диабета, статус 2017 г. Сахарный диабет. 2018;3(21):144-59
  4. Hermanides J., Nergaard K., Bruttomesso D., et al. Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabetic Medicine. 2011;28(10):1158-67. doi: 10.1111/j.1464-5491.2011.03256.x.
  5. Ибрагимова Л.И. Оценка эффективности программы обучения больных сахарным диабетом 1 типа на помповой инсулинотерапии. Дисс. канд. мед. наук (Автореферат). 2014.
  6. Шестакова М.В., Майоров А.Ю., Филиппов Ю.И. и др. Федеральные клинические рекомендациипо помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. М., 2014
  7. Melmer A., Zuger T., Pottler T., et al. Glycemic Control and Glycemic Variability Before and After Hypoglycemia in Patients with T1D Treated with MDi or CSii. Diabetes. 2019;1(68):961-P doi: 10.2337/db19-961-P.
  8. Волкова А.Р, Черная М.Е., Лискер А.В. и др. Вариабельность гликемии у пациентов с сахарным диабетом типа 1 на разных видах инсулинотерапии. Эндокринология: новости, мнения, обучение. 2019;8(3):38-43. doi: 10.24411/2304-9529-2019-13004
  9. Pickup J.C. is insulin pump therapy effective in Type 1 diabetes? Diabet Med. 2019;36(3):269-78. doi: 10.1111/dme.13793.
  10. Orr C.J., Hopman W., Yen J.L., Houlden R.L. Longterm efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus. Diabetes Technol Ther. 2015;17(1):49-54. doi: 10.1089/dia.2014.0131.
  11. Martyn-Nemeth P, Quinn L., Penckofer S., et al. Fear of hypoglycemia: influence on glycemic variability and self-management behavior in young adults with type 1 diabetes. J Diabetes Complications. 2017;31(4):735-41. doi: 10.1016/j.jdiacomp.2016.12.015.
  12. American Diabetes Association. Standards of medical care in diabetes-2019. Diabetes Care. 2019;42:1-193.
  13. Майоров А.Ю., Суркова Е.В., Мотовилин О.Г. и др. Обучение больных диабетом: синтез доказательной медицины и психологического подхода. Сахарный диабет. 2011;1:46-50.
  14. Мотовилин О.Г., Шишкова Ю.А., Суркова Е.В.Рациональный и эмоциональный компоненты отношения к болезни пациентов с сахарным диабетом 1 типа: взаимосвязь с психологическим благополучием. Сахарный диабет. 2014;3:60-9
  15. Gazzaruso C., Fodaro M., Coppola A. Structured therapeutic education in diabetes: is it time to re-write the chapter on the prevention of diabetic complications? Endocrine. 2016;53(2):347-49. doi: 10.1007/s12020-016-0947-0.
  16. Greenwood D., Gee P, Fatkin K., Peeples M. A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support. J Diabetes Sci Technol. 5017;! 1 (5/10doi: 10.1177/1932296817713506.
  17. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова, 9-й выпуск (дополненный). М., 2019.
  18. Mouslech Z., Somali M., Sarantis L., et al. Significant effect of group education in patients with diabetes type 1. 2018;17(3):397-403. doi: 10.1007/s42000-018-0054-0.
  19. Hill N., Oliver N., Choudhary P, et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther. 2011;9(13):921-28. Doi: 10.1089/ dia.2010.0247.
  20. Mazze R., Strock E., Wesley D., et al. Characterizing Glucose Exposure for individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis. Diabetes Technol Ther. 2008;3(10):149-doi: 10.1089/dia.2007.0293.
  21. Nomura K., Saitoh T., Kim G., Yamanouchi T. Glycemic Profiles of Healthy individuals with Low Fasting Plasma Glucose and HbA1c. iSRN Endocrinology. 2011;2011:435047. doi: 10.5402/2011/435047.
  22. Волкова А.Р., Черная М.Е., Мозгунова В.С. и др. Вклад вариабельности гликемии и страха гипогликемических состояний в контроль сахарного диабета 1 типа. РМЖ. Медицинское обозрение. 2020;4(6):324-28

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies